Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/17/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Michele Tagliati

Wrong Dr. Michele Tagliati?

Medical Director, Movement Disord...

Phone: (310) ***-****  HQ Phone
Email: m***@***.org
Cedars-Sinai Medical Center
8700 Beverly Blvd.
Los Angeles , California 90048
United States

Company Description: Cedars-Sinai Medical Center is one of the largest non-profit academic medical centers in the Western United States. For the fifth straight two-year period,...   more

Employment History

Board Memberships and Affiliations

  • Board Member
    American Academy of Neurology annual meetings


  • MD
  • medical degree
    University of Rome , Italy
146 Total References
Web References
Dr. Michele Tagliati, ..., 17 Nov 2015 [cached]
Dr. Michele Tagliati, MD Dr. Tagliati, is Director of the Movement Disorders Program in the Department of Neurology at Cedars-Sinai Medical Center. Dr. Tagliati is one of the world's pioneers in deep brain stimulation (DBS) and is an authority on the use of botulinum toxin injection therapy in the control of involuntary muscle contractions. Dr. Tagliati previously served as Division Chief of Movement Disorders at Mount Sinai Medical Center in New York. He specializes in all forms of movement disorders, including tremor, dystonia, chorea, tics and Parkinson's disease. He often serves in leadership and advisory roles with such organizations as the American Academy of Neurology, the Movement Disorder Society, the National Institutes of Health, the Parkinson Study Group, the National Parkinson Foundation, the Dystonia Medical Research Foundation and the Parkinson Alliance. Dr. Tagliati has lectured internationally on deep brain stimulation management and currently serves as director of the educational course on DBS programming at the American Academy of Neurology annual meetings. he author of more than 80 articles in peer-reviewed publications, Dr. Tagliati has written more than 20 chapters in medical textbooks. He also co-authored the book "Parkinson's Disease for Dummies,"and is currently a member of the editorial board of Journal of Parkinson's Disease. Dr. Tagliati earned his medical degree from the University of Rome, Italy, where he also completed a residency in neurology and a fellowship in clinical neurophysiology. He completed an internship and second neurology residency at Mount Sinai. He then completed a fellowship in movement disorders at Beth Israel Medical Center in New York.
Neurology Department Expert Team - Cedars-Sinai, 14 June 2015 [cached]
Michele Tagliati, MD
Michele Tagliati, MD
Medical Director, Movement Disorders Program
Learn More
Led by Michele Tagliati, MD, ..., 11 July 2013 [cached]
Led by Michele Tagliati, MD, director of Cedars-Sinai Medical Center's Movement Disorders Program, the study identified variables that affect impedance - resistance in circuits that affect intensity and wavelength of electrical current. Doctors who specialize in programming DBS devices fine-tune voltage, frequency and other parameters for each patient; deviations from these settings may have the potential to alter patient outcomes.
"Deep brain stimulation devices are currently designed to deliver constant, steady voltage, and we believe consistency and reliability are critical in providing therapeutic stimulation. But we found that we cannot take impedance stability for granted over the long term," said Tagliati, the senior author of a journal article that reveals the study's findings.
"Doctors with experience in DBS management can easily make adjustments to compensate for these fluctuations, and future devices may do so automatically," he added.
Tagliati, an expert in device programming, has received speaker honoraria from Medtronic Inc. and consultation fees from St. Jude Medical Inc. (formerly Advanced Neuromodulation Systems), Boston Scientific, AbbVie Inc., Allergan and Impax Laboratories Inc., unrelated to this study.
"Since Parkinson's disease patients ..., 1 Jan 2005 [cached]
"Since Parkinson's disease patients experience symptoms such as tremors, rigidity and episodes of decreased movement or complete immobility, especially in the morning, compliance and access to medication can be a problem," said Michele Tagliati, MD, Director of the Parkinson's Disease Center at the Mount Sinai Medical Center in New York.
Parkinson's Med: June 2009, 1 June 2009 [cached]
"Ultimately patients benefit from the development of new technologies," said Michele Tagliati, M.D., associate professor of neurology and division chief of movement disorders at Mount Sinai Medical Center in New York who enrolled the first patient in the study.
Other People with the name "Tagliati":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.